Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $10.2 million.

GUIDANCE:

Apyx Medical Corp. sees FY2021 revenue of $44-45 million, versus the consensus of $41.7 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.